Cancer diagnosis in areas of conflict.

Middle East cancer diagnosis conflict imaging refugees resources war

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 02 11 2022
accepted: 02 12 2022
entrez: 9 1 2023
pubmed: 10 1 2023
medline: 10 1 2023
Statut: epublish

Résumé

To date, many Arab countries within the Middle East are facing political, financial, and social instability from war and conflicts. These conflicts have led to severe resources shortages and sometimes complete breakdowns in cancer care and diagnosis. Cancer diagnosis at early stages is the most vital step in achieving optimal cancer care and outcomes. Shortages in cancer diagnostic services have meant that many people within areas of conflict are ultimately deprived of these services in their own countries. Therefore, many of these cancer sufferers must bear travel expenses to neighboring countries in order to seek these services. A lack of prevention, screening, and diagnostic services for this population is known to deepen the cancer care deficit within these areas. Additionally, the financial burden of traveling abroad alongside the need to secure childcare and time off work can be overwhelming. As a result, patients within areas of conflict are frequently diagnosed at later stages and are less likely to receive optimal management plans. Though conflict-affected regions encounter many similar challenges in delivering quality cancer care, pronounced region-specific differences do exist. Therefore, it is important to build a roadmap that can provide tailored solutions to deficits in instruments, manpower, and facilities for each and every region involved. Keeping in mind the importance of collaboration and coordination on national and international levels to address the ground disparity in cancer diagnostic services, the main objective of this review article is to examine the significant problems, shortages, and difficulties in providing cancer diagnosis with a focus on imaging to conflict-affected populations in the Middle East (mainly Iraq, Syria, Yemen, and Sudan). Finally, we discuss how access to cancer diagnostic imaging services has been impacted by these conflicts.

Identifiants

pubmed: 36620568
doi: 10.3389/fonc.2022.1087476
pmc: PMC9815758
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1087476

Informations de copyright

Copyright © 2022 Al-Ibraheem, Abdlkadir, Mohamedkhair, Mikhail-Lette, Al-Qudah, Paez and Mansour.

Déclaration de conflit d'intérêts

The authors declare that this review article was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Semin Nucl Med. 2016 Jul;46(4):265-72
pubmed: 27237437
Anticancer Res. 2016 Jan;36(1):279-86
pubmed: 26722054
Med Confl Surviv. 2013 Jan-Mar;29(1):7-25
pubmed: 23729095
Nucl Med Mol Imaging. 2019 Feb;53(1):7-10
pubmed: 30828393
Cancer Med. 2015 Mar;4(3):447-56
pubmed: 25641872
J Glob Oncol. 2018 Oct;4:1-6
pubmed: 30307806
J Glob Oncol. 2016 Aug 31;3(4):338-345
pubmed: 28831442
Lancet Oncol. 2020 May;21(5):637-644
pubmed: 32359488
J Pediatr Hematol Oncol. 2011 Oct;33 Suppl 2:S154-6
pubmed: 21952575
Lancet Oncol. 2018 Mar;19(3):291-292
pubmed: 29508747
Am Soc Clin Oncol Educ Book. 2018 May 23;38:433-440
pubmed: 30231320
BMJ Glob Health. 2021 Feb;6(2):
pubmed: 33619039
Cancer Med. 2014 Aug;3(4):1075-84
pubmed: 24821265
Int J Health Plann Manage. 2012 Jul-Sep;27(3):198-225
pubmed: 22532485
Lancet Oncol. 2020 Aug;21(8):1077-1088
pubmed: 32758462
JCO Glob Oncol. 2020 Feb;6:59-66
pubmed: 32031440
Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):523-529
pubmed: 32976784
Clin Transl Radiat Oncol. 2019 Aug 19;19:46-51
pubmed: 31497656
Nucl Med Commun. 2018 Apr;39(4):283-289
pubmed: 29381585
Am Soc Clin Oncol Educ Book. 2017;37:395-402
pubmed: 28561641
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Oman Med J. 2021 Jan 31;36(1):e219
pubmed: 33552559

Auteurs

Akram Al-Ibraheem (A)

Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan.
School of Medicine, The University of Jordan, Amman, Jordan.

Ahmed Saad Abdlkadir (AS)

Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan.

Ali Mohamedkhair (A)

Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan.

Miriam Mikhail-Lette (M)

Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.

Mohammad Al-Qudah (M)

Department of Microbiology and Pathology - Faculty of Medicine - The Hashemite University, Zarqa, Jordan.

Diana Paez (D)

Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.

Asem H Mansour (AH)

Department of Diagnostic Radiology, King Hussein Cancer Center, Amman, Jordan.

Classifications MeSH